Frost.com - Pharmaceuticals and Biotechnology Research

- Pharmaceuticals and Biotechnology Research

02/05/2010 05:00 AM
Nutrition Research Alert. Western Style Diet and Colorectal Cancer; Obesity Indicators and Cardiometabolic Status in Preschool Children; Effect of Dietary Fiber on Body Weight and Waist Circumference
This issue profiles obesity indicators and cardiometabolic status in preschool children, effect of dietary fiber on body weight and waist circumference, and association between dietary protein intake and calcium metabolism.

02/03/2010 12:00 AM
Risk-Sharing & Value-Based Pricing Schemes
There is clearly an increasing need for more innovative pricing and reimbursement agreements to help to balance the often conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA), physicians and patients.

02/03/2010 12:00 AM
Enhancing Performance of Early Phase Drug Developement Projects
The pharmaceutical industry is constantly facing increasing demands for efficiency and cost effectiveness, making the development of project management skills and tools combined with their flawless application critical to deliver the best chance of success for a new compound.

01/29/2010 11:14 PM
Genetic Technology Alert. Improved HCV Therapy through New DNA-Based Technology; Cells Responsible for Childhood Leukemia Identified; New Insights into Brain Development and Function
This issue profiles improved HCV therapy through new DNA-based technology, researchers identify cells responsible for childhood leukemia, and new insights into brain development and function. Strategic partnership details and some important patents have also been included.

01/29/2010 10:59 PM
Medical Devices Technology Alert. Linear Micro Motor for Medical Applications; Gastric Electrical Stimulation for Type 2 Diabetes; Endothelial Cells Engineered To Grow Blood Vessels
This issue profiles a a linear micro motor used for medical applications, gastric electrical stimulation for type 2 diabetes, and endothelial cells engineered to grow blood vessels.

01/15/2010 12:44 AM
Drug Discovery Technology Alert. Compound Targeting Huntington s Disease Developed; Tarantula-Derived Peptide can Treat Muscular Dystrophy; Agent That Reduces Tumor Resistance Identified
This issue profiles the development of a compound targeting Huntington's disease; a tarantula-derived peptide that can treat muscular dystrophy, and an agent that reduces tumor resistance.

01/15/2010 12:30 AM
Medical Devices Technology Alert. Device for Opening Chronic Total Occlusions in Peripheral Arteries; Drug Delivery Device for Treatment of Diabetic Eye Diseases; MEMS-Based Retinal Implant
This issue profiles a device for opening chronic total occlusions in peripheral arteries, a drug delivery device for treatment of diabetic eye diseases, and a MEMS-based retinal implant.

01/12/2010 12:00 AM
PharmaSource 2010
In its 3rd year CPhI's annual conference, PharmaSource, has assembled an outstanding panel of global Big Pharma sourcing experts who will exclusively reveal how they are driving down cost across their supply chains by utilising emerging market suppliers, and how you can too!

01/08/2010 01:12 AM
Genetic Technology Alert. Telomere Length Could Determine Longevity; Humanized Antibodies for Chronic Disease Indications; Regenerative Cells for AMD Treatment
This issue profiles a discovery that telomere length could determine longevity, and using humanized antibodies for chronic disease indications. Strategic partnership details and some important patents have also been included.

01/01/2010 03:09 AM
Medical Devices Technology Alert. Encapsulation of AP in Chitosan Nanoparticles for Drug Delivery; Lab-in-a-Box PCR Technology; Collection of UCB Stem Cells in a Cost-Effective Manner
This issue profiles encapsulation of AP in chitosan nanoparticles for drug delivery applications, a lab-in-a-box PCR technology, collection of UCB stem cells in a cost-effective manner.

01/01/2010 01:08 AM
Nutrition Research Alert. Alzheimer's Disease and High-Protein Diet; Vitamin-D and Lymphoma; Role of Soy-Based Supplements in Bone Health
This issue profiles the effect of a high-protein diet on Alzheimer's disease, vitamin-D and lymphoma, and the role of soy-based supplements in bone health.

12/31/2009 11:44 PM
Recombinant and Designer Therapeutics (Technical Insights)
The report discusses the latest trends in recombinant and designer therapeutics

12/31/2009 11:35 PM
Indian Vaccine Market
The research service presents a detailed market overview of all the major diseases like HiB, MMR, pneumococcal, rabies, typhoid, Hepatitis B and Hepatitis A. The research focusses on Market drivers, Market restraints and various industry challenges along with the revenue forecasts for the period of 2006-2016. The geographical scope of the research service is limited to India.

12/31/2009 10:41 AM
The Current Status of Novel Therapeutic Strategies
This short issue based research provides a top level picture of the current status of both available and emerging therapeutic strategies in the market.

12/31/2009 09:45 AM
Life Sciences Funding - 2008
This study covers the life sciences funding scenario in Europe covering the UK, Germany, Italy, Spain, France and Italy for 2008.

12/31/2009 06:21 AM
Advances in Cardiovascular Therapy (Technical Insights)
This research service discusses the latest developments in cardiovascular therapy.

12/31/2009 04:46 AM
Advances in RNAi (Technical Insights)
This research service outlines the key global developments in the field of RNAi.

12/28/2009 11:25 AM
U.S. Colorectal Cancer Market
This research service provides the market overview, market trends, patient and revenue forecasts for colorectal cancer in the U.S. from 2006-2016. The patient population and revenue forecasts are discussed in terms of staging and line of therapy. This includes in-depth analysis of the market segmented by line of therapy providing competitive information and pipeline analysis. This research service also captures results from the Frost & Sullivan "Voice of the Customer" analysis of drug delivery in oncology. This research service serves as an update to F205-52 on the U.S. colorectal cancer market published in 2005-06.

12/22/2009 09:40 AM
Decision Support Database - Burden of Disease and Conditions

12/19/2009 06:50 PM
Overview of Indian Oncology Market
Overview of Indian oncology market presents an all-encompassing research of Oncology markets for various cancers: Breast cancer, Lung Cancer, Ovarian cancer, Prostate cancer, Head and Neck cancer, Cervical cancer, Renal cell carcinoma and Pancreatic cancer. The research focuses on pharmaceutical industry spending in various segments of cancer treatment. Cancer is the leading cause of death in India, so the Oncology therapeutic market is growing at a very high speed. The research study of this market represents the competition and strategic analysis of various segments of cancer market.

12/18/2009 06:37 AM
Genetic Technology Alert. Technique for Neutralizing Transcription Factors; Syk Protein Could Act as Tumor Suppressor; Link between Diabetes and Obesity Discovered
This issue profiles a technique for neutralizing transcription factors, syk protein that could act as a tumor suppressor, and the discovery of the link between diabetes and obesity.

12/09/2009 10:54 AM
The Healthcare CEO Perspective on Growth
The overall research objective of this research was to assess what strategies Healthcare CEOs around the globe use to grow their organizations. Specifically, we investigated the following: 1. CEOs' Growth Objectives 2. CEOs' Growth Strategy Assessment Furthermore, this research also measured the use of media as an information source among leading executives worldwide.

12/09/2009 12:00 AM
SMi presents their 2nd Annual Conference on Pre-Filled Syringes
As the market for pre-filled syringes continues to grow and drug developers seek more cost effective and less complex drug delivery options

12/09/2009 12:00 AM
Commercialisation & Market Access Strategies for Orphan & Ultra-Orphan Drugs
Frost & Sullivan is media partner for this this event which, focusing on orphan & ultra orphan drugs, will provide a fresh and original perspective on one of the most fascinating fields in market & patient access.